Wells Fargo & Company Lantern Pharma Inc. Put Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LTRN
# of Institutions
41Shares Held
1.26MCall Options Held
42.8KPut Options Held
5.6K-
Vanguard Group Inc Valley Forge, PA364KShares$1.24 Million0.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA157KShares$537,3640.01% of portfolio
-
Geode Capital Management, LLC Boston, MA86.3KShares$295,3060.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny81.8KShares$279,7560.0% of portfolio
-
Cm Management, LLC80KShares$273,6000.35% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $37M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...